EZSolution™ Crenolanib

• Catalog number
  B2626-5
• Price
  Please ask
• Size
  5 mg

• Alternative_name
  1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine, ARO 002, CP-868596
• Description
  A 10 mM (5 mg in 1.13 ml) solution of the FLT3 tyrosine kinase inhibitor Crenolanib (Cat. No. 9679) in anhydrous DMSO.
• CAS Number
  670220-88-9
• Structure Available
  Yes
• Salt Form
  No
• Molecular Formula
  C₂₆H₂₉N₅O₂
• Cell Permeable
  True
• Purity
  ≥98% by HPLC
• Handling
  Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
• Tag Line
  A highly selective and potent FLT3 tyrosine kinase inhibitor
• Storage Condition
  -20ºC
• Shipping Condition
  Gel Pack
• Shelf Life
  36 months
• PubChem CID
  10366136
• PubChem CID Link
• SMILES
  CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4
• InChi
  InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3
• InChi Key
  DYNHJHQFHQTFTP-UHFFFAOYSA-N
• Data Sheet Link
• MSDS Available
  True

• Gene target
  EZSolution™   Crenolanib  
• Short name
  EZSolution™ Crenolanib
• Alternative name
  EZSolution™ Crenolanib

Similar products